- Home
- CEAD vs ALZN Comparison
CEAD vs ALZN Comparison
Compare CEAD & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- ALZN
- Stock Information
- Founded
- CEAD 2009
- ALZN 2016
- Country
- CEAD United States
- ALZN United States
- Employees
- CEAD N/A
- ALZN N/A
- Industry
- CEAD Industrial Machinery/Components
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- CEAD Industrials
- ALZN Health Care
- Exchange
- CEAD Nasdaq
- ALZN Nasdaq
- Market Cap
- CEAD 6.9M
- ALZN 6.1M
- IPO Year
- CEAD N/A
- ALZN 2021
- Fundamental
- Price
- CEAD $8.46
- ALZN $1.04
- Analyst Decision
- CEAD
- ALZN Strong Buy
- Analyst Count
- CEAD 0
- ALZN 1
- Target Price
- CEAD N/A
- ALZN $20.00
- AVG Volume (30 Days)
- CEAD 22.9K
- ALZN 212.9K
- Earning Date
- CEAD 03-27-2025
- ALZN 03-10-2025
- Dividend Yield
- CEAD N/A
- ALZN N/A
- EPS Growth
- CEAD N/A
- ALZN N/A
- EPS
- CEAD N/A
- ALZN N/A
- Revenue
- CEAD $2,803,470.00
- ALZN N/A
- Revenue This Year
- CEAD N/A
- ALZN $322.64
- Revenue Next Year
- CEAD N/A
- ALZN N/A
- P/E Ratio
- CEAD N/A
- ALZN N/A
- Revenue Growth
- CEAD N/A
- ALZN N/A
- 52 Week Low
- CEAD $5.60
- ALZN $0.64
- 52 Week High
- CEAD $12.26
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- CEAD 49.33
- ALZN 58.05
- Support Level
- CEAD $7.90
- ALZN $0.95
- Resistance Level
- CEAD $9.45
- ALZN $1.13
- Average True Range (ATR)
- CEAD 0.86
- ALZN 0.10
- MACD
- CEAD 0.06
- ALZN 0.02
- Stochastic Oscillator
- CEAD 63.44
- ALZN 81.52
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.